Link® Megasystem-C®
by WALDEMAR LINK GmbH & Co. KG
510(k) K151008
Link® Megasystem-C® is a Class II device made by WALDEMAR LINK GmbH & Co. KG, cleared under FDA 510(k) K151008 on 26 Aug 2015, active as of 22 Oct 2026. 14 FDA recalls are linked to it.
Active
Valid until
No expiry
FDA recalls
16 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK151008 | Date26 Aug 2015 | StatusActive |
Official records
- FDA 510(k) database K151008
Recalls
-
- Ongoing Z-1512-2026
- Ongoing Z-1513-2026
- Ongoing Z-1518-2026
- Ongoing Z-1516-2026
- Ongoing Z-1522-2026
- Ongoing Z-1521-2026
- Ongoing Z-1520-2026
- Ongoing Z-1519-2026
- Ongoing Z-1517-2026
- Ongoing Z-1515-2026
- Ongoing Z-1523-2026
- Ongoing Z-1511-2026
- Ongoing Z-1514-2026
The potential for an implant with a plateau screw where the bushing could detach from the screw shaft due to a longitudinal fracture.
-
- Ongoing Z-0890-2026
The device has been delivered with a preassembled locking screw that had been inserted from the wrong side into the male taper of the femoral component.
-
- Ongoing Z-2410-2024
- Ongoing Z-2411-2024
Blind screws of the modular tibial component cannot be loosened intraoperatively,prolongation surgery due to intraoperatively change in procedure, probably to cementing technique
Timeline
- Recall initiated FDA recalls Z-1516-2026
- Recall initiated FDA recalls Z-1522-2026
- Recall initiated FDA recalls Z-1521-2026
- Recall initiated FDA recalls Z-1520-2026
- Recall initiated FDA recalls Z-1519-2026
- Recall initiated FDA recalls Z-1517-2026
- Recall initiated FDA recalls Z-1515-2026
- Recall initiated FDA recalls Z-1523-2026
- Recall initiated FDA recalls Z-1511-2026
- Recall initiated FDA recalls Z-1514-2026
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- KRO
- Device class
- Class II
- Regulation
- 21 CFR Part 888.3510
- Advisory committee
- Orthopedic
- FDA decision
- SESE Substantially Equivalent